Mutated Response Regulator graR Is Responsible for Phenotypic Conversion of Staphylococcus aureus from Heterogeneous Vancomycin-Intermediate Resistance to Vancomycin-Intermediate Resistance
Open Access
- 1 January 2008
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 52 (1) , 45-53
- https://doi.org/10.1128/aac.00534-07
Abstract
Multistep genetic alteration is required for methicillin-resistant Staphylococcus aureus (MRSA) to achieve the level of vancomycin resistance of vancomycin-intermediate S. aureus (VISA). In the progression of vancomycin resistance, strains with heterogeneous vancomycin resistance, designated hetero-VISA, are observed. In studying the whole-genome sequencing of the representative hetero-VISA strain Mu3 and comparing it with that of closely related MRSA strains Mu50 (VISA) and N315 (vancomycin-susceptible S. aureus [VSSA]), we identified a mutation in the response regulator of the graSR two-component regulatory system. Introduction of mutated graR, designated graR*, but not intact graR, designated graRn, could convert the hetero-VISA phenotype of Mu3 into a VISA phenotype which was comparable to that of Mu50. The same procedure did not appreciably increase the vancomycin resistance of VSSA strain N315, indicating that graR* expression was effective only in the physiological milieu of hetero-VISA cell to achieve a VISA phenotype. Interestingly, the overexpression of graR* increased the daptomycin MICs in both Mu3 and N315 and decreased the oxacillin MIC in N315.Keywords
This publication has 27 references indexed in Scilit:
- Role of insertion elements and yycFG in the development of decreased susceptibility to vancomycin in Staphylococcus aureusInternational Journal of Medical Microbiology, 2007
- Correlation between Reduced Daptomycin Susceptibility and Vancomycin Resistance in Vancomycin-Intermediate Staphylococcus aureusAntimicrobial Agents and Chemotherapy, 2006
- Novel Mechanism of Antibiotic Resistance Originating in Vancomycin-Intermediate Staphylococcus aureusAntimicrobial Agents and Chemotherapy, 2006
- Allelic replacement in Staphylococcus aureus with inducible counter-selectionPlasmid, 2006
- DNA Microarray-Based Identification of Genes Associated with Glycopeptide Resistance in Staphylococcus aureusAntimicrobial Agents and Chemotherapy, 2005
- Reduced Content of Lysyl-Phosphatidylglycerol in the Cytoplasmic Membrane Affects Susceptibility to Moenomycin, as Well as Vancomycin, Gentamicin, and Antimicrobial Peptides, in Staphylococcus aureusAntimicrobial Agents and Chemotherapy, 2004
- tcaA Inactivation Increases Glycopeptide Resistance in Staphylococcus aureusAntimicrobial Agents and Chemotherapy, 2004
- Cell Wall Thickening Is a Common Feature of Vancomycin Resistance in Staphylococcus aureusJournal of Clinical Microbiology, 2003
- Involvement of multiple genetic loci inStaphylococcus aureusteicoplanin resistanceFEMS Microbiology Letters, 2001
- Identification of the Up- and Down-Regulated Genes in Vancomycin-Resistant Staphylococcus aureus Strains Mu3 and Mu50 by cDNA Differential Hybridization MethodBiochemical and Biophysical Research Communications, 2000